Moleculin Biotech, Inc.
MBRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001659617
In the last 90 days, Moleculin Biotech, Inc. insiders filed 3 open-market purchases and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $518.5K in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Moleculin Biotech, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- +2 vs. Q3 2023
- Shares held
- 5.18M
- +3.03M (+140.8%) vs. Q3 2023
- Total value
- $4.44M
- +$3.51M (+379.8%) vs. Q3 2023
- New holders
- 7
- 4 more added
- Sold out
- 5
- 4 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MBRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 18 | $518.5K |
| Q1 2026 | 20 | $347.9K |
| Q4 2025 | 17 | $315.2K |
| Q3 2025 | 25 | $412.7K |
| Q2 2025 | 22 | $117.9K |
| Q1 2025 | 23 | $1.44M |
| Q4 2024 | 21 | $790.0K |
| Q3 2024 | 19 | $1.31M |
| Q2 2024 | 16 | $1.10M |
| Q1 2024 | 19 | $1.53M |
| Q4 2023 | 24 | $4.44M |
| Q3 2023 | 22 | $925.1K |
| Q2 2023 | 22 | $1.33M |
| Q1 2023 | 23 | $2.91M |
| Q4 2022 | 25 | $3.17M |
| Q3 2022 | 27 | $3.16M |
| Q2 2022 | 26 | $4.32M |
| Q1 2022 | 23 | $5.26M |
| Q4 2021 | 26 | $5.61M |
| Q3 2021 | 24 | $8.57M |
| Q2 2021 | 32 | $10.9M |
| Q1 2021 | 29 | $8.74M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Moleculin Biotech, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Hazlett, Burt & Watson, Inc. | 67 | $0 | 0.00% | +67 | New |
| GWM Advisors LLC | 2 | $2 | 0.00% | +2 | New |
| JPMorgan Chase & Co | 52 | $45 | 0.00% | +16+44.4% | Added |
| Bank of America Corp | 138 | $118 | 0.00% | +38+38.0% | Added |
| Wells Fargo & Company | 229 | $197 | 0.00% | −488−68.1% | Reduced |
| North Star Investment Management Corp. | 250 | $215 | 0.00% | 00.0% | Unchanged |
| CVA Family Office, LLC | 500 | $429 | 0.00% | +500 | New |
| Advisor Group Holdings, Inc. | 968 | $831 | 0.00% | 00.0% | Unchanged |
| Sandy Spring Bank | 1,333 | $1.15K | 0.00% | +1,333 | New |
| Morgan Stanley | 6,334 | $5.44K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 7,201 | $6.18K | 0.00% | −7,104−49.7% | Reduced |
| Sigma Planning Corp | 12,000 | $10.3K | 0.00% | −5,000−29.4% | Reduced |
| Jmac Enterprises LLC | 13,132 | $11.3K | 0.00% | 00.0% | Unchanged |
| Schmidt P J Investment Management Inc | 29,000 | $14.1K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 20,148 | $17.0K | 0.00% | +19,839+6,420.4% | Added |
| Atticus Wealth Management, LLC | 50,001 | $42.9K | 0.02% | +50,001 | New |
| Northern Trust Corp | 53,596 | $46.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 64,652 | $55.5K | 0.00% | +64,652 | New |
| State Street Corp | 71,397 | $61.3K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 129,600 | $111.0K | 0.00% | +9,400+7.8% | Added |
| BlackRock Inc. | 188,924 | $162.2K | 0.00% | −7,374−3.8% | Reduced |
| Geode Capital Management, LLC | 246,670 | $211.8K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,080,122 | $927.2K | 0.00% | 00.0% | Unchanged |
| Armistice Capital, LLC | 3,207,417 | $2.75M | 0.07% | +3,207,417 | New |
| Sio Capital Management, LLC | 0 | $0 | 0.00% | −271,230−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −30,493−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| NBC Securities, Inc. | 0 | $0 | 0.00% | −200−100.0% | Sold out |